Regional Banks

Affinity Bancshares

Affinity Bancshares released FY2026 Q1 earnings on April 24 (EST) with actual revenue of USD 8.217 M and EPS of USD 0.3599

Affinity Bancshares released FY2025 Annual Earnings on January 23, 2026 (EST) with actual revenue of USD 32.94 M and EPS of USD 1.29

Affinity Bancshares released FY2025 Q4 earnings on January 23, 2026 (EST) with actual revenue of USD 8.521 M and EPS of USD 0.3301

Affinity Bancshares released FY2025 Q3 earnings on October 24 (EST), actual revenue USD 8.346 M, actual EPS USD 0.34

Affinity Bancshares released FY2025 9 Months Earnings on October 24 (EST), with actual revenue of USD 24.42 M and EPS of USD 0.9499

Affinity Bancshares released FY2025 Q2 earnings on July 25 (EST), actual revenue USD 8.301 M, actual EPS USD 0.3299

Affinity Bancshares released FY2025 Semi-Annual Earnings on July 25 (EST), actual revenue USD 16.07 M, actual EPS USD 0.6099

Nelson Clark Sells Affinity Bancshares Stock

Affinity Bancshares Inc. Holds Annual Shareholders Meeting

Affinity Bancshares released FY2025 Q1 earnings on May 1 (EST), actual revenue USD 7.768 M, actual EPS USD 0.28

Affinity Bancshares Inc. Announces Stock Repurchase Plan, Potentially Buying Back Up to 320,480 Shares

Affinity Bancshares released FY2024 Annual Earnings on January 31, 2025 (EST) with actual revenue of 30.61 M USD and EPS of 0.83 USD

Affinity Bancshares released FY2024 Q4 earnings on January 31, 2025 (EST), with actual revenue of 7.369 M USD and actual EPS of 0.2097 USD

Affinity Bancshares released FY2024 9 Months Earnings on October 25, 2024 (EST), with actual revenue of 23.24 M USD and EPS of 0.6199 USD

Affinity Bancshares released FY2024 Q3 earnings on October 25, with actual revenue of 7.98 M USD and EPS of 0.26 USD

Atlanta Postal Credit Union Acquires Affinity Bancshares in All-Cash Deal, Stock Price Rises 22.4%

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

BRNS

AFBI

Halper Sadeh LLC is investigating Kennedy-Wilson Holdings, Barinthus Biotherapeutics, and Affinity Bancshares for potential violations of federal securities laws and breaches of fiduciary duties. The firm is concerned that insiders may benefit financially at the expense of ordinary shareholders. Shareholders are encouraged to contact the firm for legal rights and options regarding the proposed transactions, which include a sale of Kennedy-Wilson for $10.90 per share, a merger involving Barinthus, and a sale of Affinity for $23.00 per share.

prnewswire

Barinthus Biotherapeutics

Kennedy-Wilson

Fairfax Financial Holdings Limited

02:54 ETAre KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders?

CNTA

CLBK

NFBK

Class Action Attorney Juan Monteverde of Monteverde & Associates PC is investigating mergers involving Columbia Financial, Inc. (CLBK), Northfield Bancorp, Inc. (NFBK), Affinity Bancshares, Inc. (AFBI), and Centessa Pharmaceuticals plc (CNTA). The firm has a successful track record in recovering funds for shareholders and is offering free consultations. Shareholders of Affinity are expected to receive $23.00 per share, while Centessa shareholders may receive $38.00 per share plus contingent value rights. A shareholder vote is scheduled for June 12, 2026.

Centessa Pharmaceuticals

Columbia Financial

NorthField

Eli Lilly

15:12 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA

Earnings Watch

Affinity Bancshares | 10-Q: FY2026 Q1 Revenue: USD 12.9 M

Affinity Bancshares | 8-K: FY2026 Q1 Revenue: USD 12.9 M

Affinity Bancshares Non-GAAP EPS of $0.36, revenue of $8.15M

businessinsider

Affinity Bancshares Non-GAAP EPS of $0.36, revenue of $8.15M

Affinity Bancshares (NASDAQ:AFBI) reported earnings of $0.36 per share for the quarter, with a return on equity of 7.25% and a net margin of 15.74%. The company generated $8.12 million in revenue. The stock remained flat at $22.41, with a market cap of $136.48 million. Weiss Ratings upgraded the stock from "hold" to "buy". Hedge funds own 39.31% of the shares, and the company has initiated a $300,000 stock buyback plan, indicating confidence in its valuation.

Market Beat

Zacks Quality International ETF

Zacks Focus Growth ETF

Zacks Small/Mid Cap ETF

Nano Labs

Weis Markets

Carl Zeiss Meditec AG

NEUBERGER BERMAN REAL ES-W/I

GS MarketBeta US Equity ETF

MarketWise

Value Line

Jayride Group Ltd.

Cross Marketing Group, Inc.

TrueShares Structured Outcome Jan ETF

AllianceBernstein

Annaly Capital Mgmt

Instacart（Maplebear）

BigBear.ai

Janus

Michael Hill International Ltd.

Salzgitter AG

ANNALY CAPITAL MANAGEMENT INC 6.95% FXD FLTG CUM RED PFD SR F 30/09/22

ANNALY CAPITAL MANAGEMENT INC 8.875 CUM PREF SER J

ANNALY CAPITAL MANAGEMENT INC 6.750% FXD TO FTG RATE CUM RED PRF SR I

ANNALY CAPITAL MANAGEMENT INC 6.50 CUM RED PFD STK FIX FLT SER G USD25

BIGBEAR AI HOLDINGS INC C/WTS 08/12/2026 (TO PUR COM)

Affinity Bancshares (NASDAQ:AFBI) Issues Earnings Results

Affinity Bancshares, Inc. Announces First Quarter 2026 Financial Results | AFBI Stock News

StockTitan

Affinity Bancshares, Inc. Announces First Quarter 2026 Financial Results | AFBI Stock News

CRBG

AUPH

AKRO

ULYX

Halper Sadeh LLC is investigating Kezar Life Sciences, Equitable Holdings, and Urgent.ly for potential violations of federal securities laws and breaches of fiduciary duties. The firm is concerned that insiders may benefit financially at the expense of ordinary shareholders. They are encouraging shareholders to discuss their rights and options regarding the proposed transactions, which include KZR's sale to Aurinia Pharmaceuticals, EQH's merger with Corebridge Financial, and ULYX's sale to Agero. Halper Sadeh LLC offers legal assistance on a contingent fee basis.

Urgently

Equitable

Corebridge Financial

Aurinia Pharma

Akero Therapeutics

Kezar Life Sciences

Urgent.ly Inc.

16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?

Affinity Bancshares, Inc. (NASDAQ:AFBI) experienced a significant increase in short interest, rising 102.4% in March to 11,802 shares. This represents approximately 0.2% of the company's shares sold short, with a short-interest ratio of 0.3 days based on an average daily trading volume of 37,172 shares. The stock opened at $22.31, with a market cap of $135.87 million and a P/E ratio of 17.29. Analysts maintain a consensus "Hold" rating on the stock, while institutional investors hold 39.31% of shares.

Short Interest in Affinity Bancshares, Inc. (NASDAQ:AFBI) Expands By 102.4%

Affinity Bancshares(AFBI.US)

02:54 ETAre KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders?

15:12 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA

Affinity Bancshares | 10-Q: FY2026 Q1 Revenue: USD 12.9 M

Affinity Bancshares | 8-K: FY2026 Q1 Revenue: USD 12.9 M

Affinity Bancshares Non-GAAP EPS of $0.36, revenue of $8.15M

Affinity Bancshares (NASDAQ:AFBI) Issues Earnings Results

Affinity Bancshares, Inc. Announces First Quarter 2026 Financial Results | AFBI Stock News

16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?

Short Interest in Affinity Bancshares, Inc. (NASDAQ:AFBI) Expands By 102.4%